Pluristyx

Private

Seattle, WashingtonHealthcare & Life Scienceshttps://pluristyx.com/

Last Round

Seed Round

Jul 13, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Pluristyx is a biotechnology company that provides induced pluripotent stem cell (iPSC) products, contract development, and manufacturing services to accelerate the development of cell and gene therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

induced pluripotent stem cellsiPSCscell therapygene editingCDMO servicesoff-the-shelf cell therapyallogeneic cell therapyimmune evasion technologyimmune cloakingcell therapy safety switchkill switch technologyregenerative medicinecell line developmentGMP cell linesCMC supportcellular reprogrammingorganoid productsAI-augmented cell manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pluristyx Comparables

Compare Pluristyx with similar companies based on industry and business-model similarity.

Pluristyx comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Cellistic	78%
Ncardia	77%
bit.bio	77%

View all Comparables

Pluristyx Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed Round	Jul 13, 2026
Grant	Nov 17, 2025
Convertible Debt	Jul 28, 2025
Early Funding	Dec 21, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Jason Carstens

Chief Operating Officer And Co-Founder, Chairman Of The Board

Founding Team

Benjamin Fryer

Co-Founder And CEO

Founding Team

Priya Baraniak

Chief Commercial And Development Officer, Director, Board Of Directors

Executive Team

Pluristyx Investors

Notable investors and investment history

Pluristyx investors
Investor	Rounds
JDRF	Grant
BroadOak Capital Partners	Early Funding, Convertible Debt

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 19, 2026
Monthly visitors grew 97% MoM, reaching 3.7K.
Jan 27, 2026
Monthly visitors increased 33% MoM.

View all signals

Pluristyx Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Pluristyx Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pluristyx's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington

Employee Range16

Year Founded2018

Last FundingJul 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.